MyoScience
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $3.2m | Series A | |
$10.4m | Series B | ||
N/A | $39.0m | Series C | |
$33.0m | Series D | ||
$25.0m | Series E | ||
N/A | $14.0m | Late VC | |
$10.0m | Early VC | ||
$220m Valuation: $220m | Acquisition | ||
Total Funding | $135m |
Related Content
Recent News about MyoScience
EditMyoscience operates in the medical technology sector, specializing in cryoanalgesia solutions designed to provide immediate and long-lasting non-opioid pain relief. The company's core product is a handheld device that targets both superficial and deep nerves, making it suitable for various clinical settings. Myoscience primarily serves healthcare providers, including doctors and clinics, who incorporate their technology into pain management practices. The business model revolves around selling these advanced medical devices and offering comprehensive support and resources to healthcare professionals for effective implementation. Revenue is generated through direct sales of the devices and potentially through service agreements for ongoing support and training.
Keywords: cryoanalgesia, non-opioid, pain relief, handheld device, medical technology, healthcare providers, nerve targeting, clinical settings, pain management, innovative solutions.